Author

Radwa Ewaisha

Faculty of Pharmacy - Alexandria University - Cited by 252

Biography

Dr. Radwa Ewaisha  is from USA. She had done her Doctor of Philosophy from Arizona State University | ASU · Center for Personalized Diagnostics, USA. She published more than 23 articles in many journals and the articles are informative and got good number of citations. Her research interests mostly focus on proteins, protein expression, cloning, DNA, protein purification, PCR and cell culture.
Title
Cited by
Year
Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes.
SR Ferdosi, R Ewaisha, F Moghadam, S Krishna, JG Park, ...Nature communications 10 (1), 1842-1842, 2019201
130
2019
Fusion protein comprised of the two schistosomal antigens, Sm14 and Sm29, provides significant protection against Schistosoma mansoni in murine infection model
SF Mossallam, EI Amer, RE Ewaisha, AM Khalil, HM Aboushleib, ...BMC infectious diseases 15 (1), 1-16, 2015201
23
2015
Serum immune profiling for early detection of cervical disease
R Ewaisha, G Panicker, P Maranian, ER Unger, KS AndersonTheranostics 7 (16), 3814, 2017201
21
2017
Serum Immune Profiling for Early Detection of Cervical Disease
R Ewaisha, G Panicker, P Maranian, ER Unger, KS AndersonTheranostics 7 (16), 3814, 2017201
21
2017
Programmable protein arrays for immunoprofiling HPV‐associated cancers
R Ewaisha, I Meshay, J Resnik, BA Katchman, KS AndersonProteomics 16 (8), 15-1224, 2016201
21
2016
Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection
RE Ewaisha, M Bahey-El-Din, SF Mossallam, EI Amer, HM Aboushleib, ...Experimental parasitology 145, 51-60, 141
20
2014
Vaccine Design
S Thomas, GC PrendergastSpringer New York, 2016201
13
2016
Crucial considerations for pipelines to validate circulating biomarkers for breast cancer
R Ewaisha, CD Gawryletz, KS AndersonExpert review of proteomics 13 (2), 201-211, 2016201
9
2016
Limited Correlation between SARS-CoV-2 Serologic Assays for Identification of High-Titer COVID-19 Convalescent Plasma Using FDA Thresholds
NE Larkey, R Ewaisha, MA Lasho, MM Roforth, D Granger, CR Jerde, ...Microbiology Spectrum 10 (), e0115-22, 2022202
4
2022
Proteomic monitoring of B cell immunity
R Ewaisha, KS AndersonVaccine Design: Methods and Protocols: Volume 1: Vaccines for Human Diseases …, 01601
2
2016
Successful detection, expression and purification of the alternatively spliced truncated Sm14 antigen of an Egyptian strain of Schistosoma mansoni
RE Ewaisha, M Bahey-El-Din, SF Mossallam, AM Khalil, HM AboushleibJournal of helminthology 89 (6), 764-768, 01501
2
2015
Immunogenicity of CRISPR therapeutics—Critical considerations for clinical translation
R Ewaisha, KS AndersonFrontiers in Bioengineering and Biotechnology , 38596, 2023202
1
2023
Low-cost, disposable fluorescence-based biorecognition system architecture for multiplexed point-of-care molecular diagnostics
JT Smith, U Obahiagbon, R Ewaisha, BA Katchman, K Kaftanoglu, ...206 IEEE Healthcare Innovation Point-Of-Care Technologies Conference (HI …, 20620
1
2016

Referred From: https://scholar.google.com/citations?user=KY-i3Y8AAAAJ&hl=en&oi=sra

Cited by
Citations 252
h-index 7
i10-index 6
Recommended Journals
Open Access Journals